These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15767450)

  • 1. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.
    Chen A; Divisconte M; Jiang X; Quink C; Wang F
    J Virol; 2005 Apr; 79(7):4506-9. PubMed ID: 15767450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A; Zhao B; Kieff E; Aster JC; Wang F
    J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
    Jiang H; Cho YG; Wang F
    J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBNA2 and Its Coactivator EBNA-LP.
    Kempkes B; Ling PD
    Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI; Wang F; Mannick J; Kieff E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.
    Cancian L; Bosshard R; Lucchesi W; Karstegl CE; Farrell PJ
    PLoS Pathog; 2011 Jul; 7(7):e1002164. PubMed ID: 21857817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
    Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro.
    Tomkinson B; Kieff E
    J Virol; 1992 May; 66(5):2893-903. PubMed ID: 1313908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
    Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES
    J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
    Roth G; Curiel T; Lacy J
    Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
    Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
    Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ; Crawford DH; Griffin BE
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote naïve B cell transformation.
    Cable JM; Reinoso-Vizcaino NM; White RE; Luftig MA
    PLoS Pathog; 2024 Jul; 20(7):e1011950. PubMed ID: 39083560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate.
    Inoue N; Kikuta H; Yanagi K
    Intervirology; 1992; 33(4):180-6. PubMed ID: 1339417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immortalizing genes of Epstein-Barr virus.
    Middleton T; Gahn TA; Martin JM; Sugden B
    Adv Virus Res; 1991; 40():19-55. PubMed ID: 1659776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
    Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.
    Yoo LI; Woloszynek J; Templeton S; Speck SH
    J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
    Kinoshita T
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.